Re-evaluation of the diagnostic performance of 11C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomas

D Kim, JH Chun, SH Kim, JH Moon, SG Kang… - European journal of …, 2019 - Springer
Purpose We evaluated the usefulness of 11 C-methionine (MET) positron emission
tomography/computed tomography (PET/CT) for grading cerebral gliomas according to the …

Diagnostic performance of [11C] methionine positron emission tomography in newly diagnosed and untreated glioma based on the revised World Health organization …

K Nakajo, T Uda, T Kawashima, Y Terakawa… - World neurosurgery, 2021 - Elsevier
Background The relationship between uptake of amino acid tracer with positron emission
tomography (PET) and glioma subtypes/gene status is still unclear. Objective To assess the …

[HTML][HTML] Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification

T Ogawa, N Kawai, K Miyake, A Shinomiya… - EJNMMI research, 2020 - Springer
Background The molecular features of isocitrate dehydrogenase (IDH) mutation and
chromosome 1p and 19q (1p/19q) codeletion status have pivotal role for differentiating …

Comparison of L-methyl-11C-methionine PET with magnetic resonance spectroscopy in detecting newly diagnosed glioma

S Kebir, L Lazaridis, M Weber, C Deuschl… - Clinical nuclear …, 2019 - journals.lww.com
Aims Amino acid PET and magnetic resonance spectroscopy (MRS) are at the forefront of
noninvasive imaging techniques used for detection and subtyping of glioma-suspicious …

Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l …

W Zhou, J Wen, Q Huang, Y Zeng, Z Zhou… - European Journal of …, 2024 - Springer
Purpose Determination of isocitrate dehydrogenase (IDH) genotype is crucial in the
stratification of diagnosis and prognostication in diffuse gliomas. We sought to build and …

Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous …

H Takei, J Shinoda, S Ikuta, T Maruyama… - Journal of …, 2019 - thejns.org
OBJECTIVE Positron emission tomography (PET) is important in the noninvasive diagnostic
imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 …

Hybrid 11C-MET PET/MRI combined with “machine learning” in glioma diagnosis according to the revised glioma WHO classification 2016

S Kebir, M Weber, L Lazaridis, C Deuschl… - Clinical nuclear …, 2019 - journals.lww.com
Purpose With the advent of the revised WHO classification from 2016, molecular features,
including isocitrate dehydrogenase (IDH) mutation have become important in glioma …

[HTML][HTML] Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma

K Nakajo, T Uda, T Kawashima, Y Terakawa… - Scientific Reports, 2022 - nature.com
This study aimed whether the uptake of amino tracer positron emission tomography (PET)
can be used as an additional imaging biomarker to estimate the prognosis of glioma …

IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas

A Verger, P Metellus, Q Sala, C Colin, E Bialecki… - European journal of …, 2017 - Springer
Abstract Purpose The World Health Organization Classification of Tumors of the Central
Nervous System has recently been updated by the integration of diagnostic and prognostic …

[HTML][HTML] Sex-specific radiomic features of L-[S-methyl-11C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability

L Papp, S Rasul, CP Spielvogel, D Krajnc… - Frontiers in …, 2023 - frontiersin.org
Introduction Amino-acid positron emission tomography (PET) is a validated metabolic
imaging approach for the diagnostic work-up of gliomas. This study aimed to evaluate sex …